US Patent
US11590286 — Devices, systems and methods for medicament delivery
Formulation · Assigned to kaleo Inc · Expires 2026-12-12 · 1y remaining
Vulnerability score
68/100
Moderate — design-around opportunities exist
What this patent protects
This patent protects a method for a medical injector's actuation lock mechanism, allowing it to move from a first position to a second position.
USPTO Abstract
A method includes moving an actuation lock of a medical injector from a first position to a second position. The actuation lock has an extended portion disposed between a shoulder of a housing and the base when the actuation lock is in the first position. The extended portion is spaced apart from the base when the actuation lock is in the second position. A distal end portion of a base, which is movably coupled to an end portion of the housing, is placed into contact with a body. The base is actuated after the placing to release an energy from an energy storage member within the housing to produce a force to move a needle from a first needle position to a second needle position. At least a portion of the needle extends through the base when the needle is in the second needle position.
Drugs covered by this patent
- Epipen (epinephrine) · Pfizer Inc.
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.